Dimitar Slavchev Savov
CIK: 0002019433
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NIKA
NIKA PHARMACEUTICALS, INC
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
About Savov Dimitar Slavchev
Savov Dimitar Slavchev (SEC CIK 0002019433) files insider reports with the SEC as CEO, CFO, President of NIKA PHARMACEUTICALS, INC (NIKA).
Signal8 holds 1 ownership filing by Savov Dimitar Slavchev, a Form 4, filed on Mar 19, 2025. Those filings report 1 transaction, the latest on Mar 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Savov Dimitar Slavchev's filings is in SOFIA, E0.
Recent filings by Savov Dimitar Slavchev
- Mar 18, 2025: Open-market sale of NIKA shares (Form 4, code S).